2013 ICD-9-CM Diagnosis Code 189.0 Malignant neoplasm of kidney, except pelvis Short description: Malig neopl kidney. ICD-9-CM 189.0 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 189.0 should only be used for claims with a date of service on or before September 30, 2015.
ICD-9 Code 189.0 Malignant neoplasm of kidney, except pelvis. ICD-9 Index; Chapter: 140–239; Section: 179-189; Block: 189 Malignant neoplasm of kidney and other and unspecified urinary organs; 189.0 - Malig neopl kidney
2015 ICD-9-CM Diagnosis Code 189.1 Malignant neoplasm of renal pelvis 2015 Billable Thru Sept 30/2015 Non-Billable On/After Oct 1/2015 ICD-9-CM 189.1 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 189.1 should only be used for claims with a date of service on or before September 30, 2015.
ICD-9 Codes Neoplasms Malignant Neoplasm Of Genitourinary Organs (189.0) 189 189.0 189.1 Malignant neoplasm of kidney except pelvis (189.0) ICD-9 code 189.0 for Malignant neoplasm of kidney except pelvis is a medical classification as listed by WHO under the range -MALIGNANT NEOPLASM OF GENITOURINARY ORGANS (179-189).
Entry | H01691 Disease |
---|---|
Other DBs | ICD-11: 2F35 ICD-10: D30.0 MeSH: D018207 |
Reference | PMID:26612197 (gene, drug) |
Authors | Flum AS, Hamoui N, Said MA, Yang XJ, Casalino DD, McGuire BB, Perry KT, Nadler RB |
Title | Update on the Diagnosis and Management of Renal Angiomyolipoma. |
Approximate Synonyms. Cancer of the kidney. Cancer of the kidney, primary, localized. Cancer of the kidney, renal cell. Cancer of the kidney, sarcoma. Cancer of the kidney, transitional cell carcinoma. Cancer of the kidney, wilms tumor. Clear cell carcinoma of kidney. Localized primary malignant neoplasm of kidney.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
The 2022 edition of ICD-10-CM C64.9 became effective on October 1, 2021.
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM C64.2 became effective on October 1, 2021.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM D49.512 became effective on October 1, 2021.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.